Skip to content

Investigating the use of the Mindcotine® virtual reality smartphone app to help people to quit smoking

Virtual reality smartphone-based smoking cessation: A pilot RCT on initial clinical efficacy and adherence

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN50586181
Enrollment
120
Registered
2019-10-03
Start date
2017-11-13
Completion date
Unknown
Last updated
2020-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nicotine addiction Mental and Behavioural Disorders

Interventions

The design of the study follows the recommendations for clinical trials in health using virtual reality, in particular Tier VR 2, focusing on acceptability, feasibility, tolerability, and initial clin

Sponsors

Universidad de Flores
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 24 to 65 years 2. Minimum consumption of 5 cigarettes per day 3. Score of 4-9 on the Contemplation Scale (CL) 4. Residents in the City of Buenos Aires 5. Own an Android mobile phone with gyroscope 6. Have data plan or Wi-Fi access 7. Expressed an interest in using VR as a method to quit smoking

Exclusion criteria

Exclusion criteria: 1. Diagnosed with a current psychiatric disorder

Design outcomes

Primary

MeasureTime frame
Self-reported abstinence at 1 day after the end of the program. The question used for assessment was "Did you smoke tobacco in the last 24 hours?"

Secondary

MeasureTime frame
1. Sustained abstinence, i.e. self-reported abstinence at 90 days after the end of the program in the TG. The question used for assessment was "Did you smoke tobacco in the last 90 days?" 2. Adherence assessed using log file data collected using the platform Amplitude, which measured total use of the app of each participant. Full adherence was defined as the participant completing the treatment in the suggested time (i.e. 21 days without any breaks). Regular adherence was defined as participants completing all daily activities in up to 60 days; and depth of adherence as the total number of mindfulness training minutes. 3. Cigarette consumption reported by participants as the number of cigarettes they smoked each day during treatment, as part of their daily self-reports. The daily number of cigarettes was averaged every week to generate an average number for that period. 4. Craving was assessed using the Questionnaire for Smoking Urges (QSU), which consists of a 7-point Likert scale. This data was collected through an online survey at baseline, at the end of days 7 and 14, and on 1-day follow-up, as well as on 90-day follow-up. The internal consistency for the overall scale was adequate (? = .87). 5. Mindfulness was assessed using the Five Facets Mindfulness Questionnaire (FFMQ). The five dimensions are: observing, describing, acting with awareness, not judging internal experience, and not reacting to internal experience. This data was collected through an online survey at baseline and at 1-day follow-up, as well as on day 90-day follow-up. 6. Readiness to quit was assessed using the Contemplation Ladder, which consists of 11 rungs and 5 anchor statements reflecting the stages of change, designed to measure readiness to quit smoking. It was assessed through an online survey at baseline and at 1-day follow up. 7. Nicotine dependence was assessed using the Fagerström Test (R

Countries

Argentina

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 18, 2026